1
|
Sitarz R, Skierucha M, Mielko J, Offerhaus
GJA, Maciejewski R and Polkowski WP: Gastric cancer: Epidemiology,
prevention, classification, and treatment. Cancer Manag Res.
10:239–248. 2018. View Article : Google Scholar : PubMed/NCBI
|
2
|
Rawla P and Barsouk A: Epidemiology of
gastric cancer: Global trends, risk factors and prevention. Prz
Gastroenterol. 14:26–38. 2019.PubMed/NCBI
|
3
|
Mocellin S, Verdi D, Pooley KA and Nitti
D: Genetic variation and gastric cancer risk: A field synopsis and
meta-analysis. Gut. 64:1209–1219. 2015. View Article : Google Scholar : PubMed/NCBI
|
4
|
Wadhwa R, Song S, Lee JS, Yao Y, Wei Q and
Ajani JA: Gastric cancer molecular and clinical dimensions. Nat Rev
Clin Oncol. 10:643–655. 2013. View Article : Google Scholar : PubMed/NCBI
|
5
|
Riquelme I, Saavedra K, Espinoza JA, Weber
H, García P, Nervi B, Garrido M, Corvalán AH, Roa JC and Bizama C:
Molecular classification of gastric cancer: Towards a
pathway-driven targeted therapy. Oncotarget. 6:24750–24779. 2015.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Coccolini F, Montori G, Ceresoli M, Cima
S, Valli MC, Nita GE, Heyer A, Catena F and Ansaloni L: Advanced
gastric cancer: What we know and what we still have to learn. World
J Gastroenterol. 22:11392016. View Article : Google Scholar : PubMed/NCBI
|
7
|
Giordano S and Columbano A: MicroRNAs: New
tools for diagnosis, prognosis, and therapy in hepatocellular
carcinoma? Hepatology. 57:840–847. 2013. View Article : Google Scholar : PubMed/NCBI
|
8
|
Gao F, Zhang C, Zhou C, Sun W, Liu X,
Zhang P, Han J, Xian L, Bai D, Liu H, et al: A critical role of
toll-like receptor 2 (TLR2) and its' in vivo ligands in
radio-resistance. Sci Rep. 5:130042015. View Article : Google Scholar : PubMed/NCBI
|
9
|
Zheng B, Liang L, Wang C, Huang S, Cao X,
Zha R, Liu L, Jia D, Tian Q, Wu J, et al: MicroRNA-148a suppresses
tumor cell invasion and metastasis by downregulating ROCK1 in
gastric cancer. Clin Cancer Res. 17:7574–7583. 2011. View Article : Google Scholar : PubMed/NCBI
|
10
|
Li J, Dong G, Wang B, Gao W and Yang Q:
miR-543 promotes gastric cancer cell proliferation by targeting
SIRT1. Biochem Biophys Res Commun. 469:15–21. 2016. View Article : Google Scholar : PubMed/NCBI
|
11
|
Zhou X, Zhu W, Li H, Wen W, Cheng W, Wang
F, Wu Y, Qi L, Fan Y, Chen Y, et al: Diagnostic value of a plasma
microRNA signature in gastric cancer: A microRNA expression
analysis. Sci Rep. 5:112512015. View Article : Google Scholar : PubMed/NCBI
|
12
|
Ibarrola-Villava M, Llorca-Cardeñosa MJ,
Tarazona N, Mongort C, Fleitas T, Perez-Fidalgo JA, Roselló S,
Navarro S, Ribas G and Cervantes A: Deregulation of ARID1A, CDH1,
cMET and PIK3CA and target-related microRNA expression in gastric
cancer. Oncotarget. 6:269352015. View Article : Google Scholar : PubMed/NCBI
|
13
|
Ge X, Liu X, Lin F, Li P, Liu K, Geng R,
Dai C, Lin Y, Tang W, Wu Z, et al: MicroRNA-421 regulated by HIF-1α
promotes metastasis, inhibits apoptosis, and induces cisplatin
resistance by targeting E-cadherin and caspase-3 in gastric cancer.
Oncotarget. 26:24466–24682. 2016. View Article : Google Scholar
|
14
|
Du Y, Wang L, Wu H, Zhang Y, Wang K and Wu
D: MicroRNA-141 inhibits migration of gastric cancer by targeting
zinc finger E-box-binding homeobox 2. Mol Med Rep. 12:3416–3422.
2015. View Article : Google Scholar : PubMed/NCBI
|
15
|
Xu Q, Zhu Q, Zhou Z, Wang Y, Liu X, Yin G,
Tong X and Tu K: MicroRNA-876-5p inhibits epithelial-mesenchymal
transition and metastasis of hepatocellular carcinoma by targeting
BCL6 corepressor like 1. Biomed Pharmacother. 103:645–652. 2018.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Wang Y, Xie Y, Li X, Lin J, Zhang S, Li Z,
Huo L and Gong R: miR-876-5p acts as an inhibitor in hepatocellular
carcinoma progression by targeting DNMT3A. Pathol Res Pract.
214:1024–1030. 2018. View Article : Google Scholar : PubMed/NCBI
|
17
|
Bao L, Lv L, Feng J, Chen Y, Wang X, Han S
and Zhao H: MiR-876-5p suppresses epithelial-mesenchymal transition
of lung cancer by directly down-regulating bone morphogenetic
protein 4. J Biosci. 42:671–681. 2017. View Article : Google Scholar : PubMed/NCBI
|
18
|
Song B, Ji W, Guo S, Liu A, Jing W, Shao
C, Li G and Jin G: miR-545 inhibited pancreatic ductal
adenocarcinoma growth by targeting RIG-I. FEBS Lett. 588:4375–4381.
2014. View Article : Google Scholar : PubMed/NCBI
|
19
|
Hansen MB, Nielsen SE and Berg K:
Re-examination and further development of a precise and rapid dye
method for measuring cell growth/cell kill. J Immunol Methods.
119:203–210. 1989. View Article : Google Scholar : PubMed/NCBI
|
20
|
Freimoser FM, Jakob CA, Aebi M and Tuor U:
The MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium
bromide] assay is a fast and reliable method for colorimetric
determination of fungal cell densities. Appl Environ Microbiol.
65:3727–3729. 1999. View Article : Google Scholar : PubMed/NCBI
|
21
|
Meletiadis J, Meis JF, Mouton JW, Donnelly
JP and Verweij PE: Comparison of NCCLS and 3-(4,
5-dimethyl-2-thiazyl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT)
methods of in vitro susceptibility testing of filamentous fungi and
development of a new simplified method. J Clin Microbiol.
38:2949–2954. 2000. View Article : Google Scholar : PubMed/NCBI
|
22
|
Song B, Zhang C, Li G, Jin G and Liu C:
MiR-940 inhibited pancreatic ductal adenocarcinoma growth by
targeting MyD88. Cell Physiol Biochem. 35:1167–1177. 2015.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
25
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
26
|
Grimson A, Farh KK, Johnston WK,
Garrett-Engele P, Lim LP and Bartel DP: MicroRNA targeting
specificity in mammals: Determinants beyond seed pairing. Mol Cell.
27:91–105. 2007. View Article : Google Scholar : PubMed/NCBI
|
27
|
Garcia DM, Baek D, Shin C, Bell GW,
Grimson A and Bartel DP: Weak seed-pairing stability and high
target-site abundance decrease the proficiency of lsy-6 and other
microRNAs. Nat Struct Mol Biol. 18:1139–1146. 2011. View Article : Google Scholar : PubMed/NCBI
|
28
|
Friedman RC, Farh KK-H, Burge CB and
Bartel DP: Most mammalian mRNAs are conserved targets of microRNAs.
Genome research. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
29
|
Lee S, Paulson KG, Murchison EP, Afanasiev
OK, Alkan C, Leonard JH, Byrd DR, Hannon GJ and Nghiem P:
Identification and validation of a novel mature microRNA encoded by
the Merkel cell polyomavirus in human Merkel cell carcinomas. J
Clin Virol. 52:272–275. 2011. View Article : Google Scholar : PubMed/NCBI
|
30
|
Wang RY, Weng KF, Huang YC and Chen CJ:
Elevated expression of circulating miR876-5p is a specific response
to severe EV71 infections. Sci Rep. 6:241492016. View Article : Google Scholar : PubMed/NCBI
|
31
|
Zhang H, Li Z, Li Y, Liu J, Li X, Shen T,
Duan Y, Hu M and Xu D: A computational method for predicting
regulation of human microRNAs on the influenza virus genome. BMC
Syst Biol. 7 (Suppl 2):S32013. View Article : Google Scholar : PubMed/NCBI
|
32
|
Xu J, Lamouille S and Derynck R:
TGF-beta-induced epithelial to mesenchymal transition. Cell Res.
19:156–172. 2009. View Article : Google Scholar : PubMed/NCBI
|
33
|
Katz LH, Li Y, Chen JS, Muñoz NM, Majumdar
A, Chen J and Mishra L: Targeting TGF-β signaling in cancer. Exp
Opin Therapeutic Targets. 17:743–760. 2013. View Article : Google Scholar
|
34
|
Chen J, Miao L, Jin G, Ren C, Ke Q, Qian
Y, Dong M, Li H, Zhang Q, Ding Y, et al: TGFBR1 tagging SNPs and
gastric cancer susceptibility: A two-stage case-control study in
Chinese population. Mol Carcinog. 53:109–116. 2014. View Article : Google Scholar : PubMed/NCBI
|